A Study to Assess the Bioequivalence of Dapagliflozin/Metformin XR Fixed-dose Combination Tablets in Healthy Subjects
Status:
Completed
Trial end date:
2016-04-07
Target enrollment:
Participant gender:
Summary
This is a bioequivalence study to compare 2 fixed-dose combination tablets of
dapagliflozin/metformin XR manufactured at 2 different plants in healthy subjects under
fasting and fed conditions